Karyopharm Therapeutics (KPTI) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 9:00 A.M. Eastern Time on February 18, 2026, in a virtual format, ensuring stockholders' participation rights.

• Michael Mano appointed as secretary and inspector of election; oath taken and filed with meeting minutes.

• Rules of conduct for participation and question submission outlined at the start.

Specific resolutions to be voted on

• Proposal One: Amendment to increase authorized capital stock from 58,333,333 to 111 million and common stock from 53,333,333 to 106 million.

• Proposal Two: Approval to adjourn the meeting if more time is needed for proxy solicitation regarding Proposal One.

Q&A with stakeholders

• Stockholders invited to submit questions online, limited to the proposals.

• No questions were submitted regarding the proposals.